Control: Clinical Trials

137 trials of Control, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

137 completed. 137 Phase 2, 34 Phase 3, 24 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 2137Completed 137
Phase 334Completed 34
Phase 124Completed 24

Follow Control: new trials by email Literature Review of Control trials Research Report on Control

Trials (filtered) newest first · largest first

All 137 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nurse-Led Elderly Sleep Intervention
Otago programme, Otago programme + Cognifit, Control - Sleep, Gerontology
Phase 1 / Phase 2CompletedUniversity of Castilla-La Mancha662025-09-012026-05-22
A Study to Assess Adverse Events and Effectiveness of Intradermally Injected JUVÉDERM® VOLITE™ Gel Filler in Adult Participants For the Improvement of Skin Quality
JUVÉDERM® VOLITE™, Control - Skin Quality Deficit
Phase 2 / Phase 3CompletedAbbVie1352024-07-182026-02-18
Effects of Platelet-Rich Fibrin on Postoperative Outcomes Following Nasosinusal Surgery
Platelet-rich fibrin (PRF), Control - Turbinate Surgery
Phase 1 / Phase 2CompletedHospital Edmundo Vasconcelos142024-06-152026-06-12
Efficacy of Inhaled Methoxyflurane (Penthrox) as Adjunct for Urologic Procedures Under Local Anesthetic: A Pilot Study
Methoxyflurane, Control - Scrotum Disease, Hydrocele Male
Phase 2CompletedUniversity of Manitoba402024-04-172025-09-25
A Phase 2 Clinical Trial of VLA1553 in Healthy Children Aged 1 to 11 Years
VLA1553 full dose, VLA1553 half dose, Control - Chikungunya Virus Infection
Phase 2CompletedValneva Austria GmbH3042023-12-182026-08-13
Safety and Impact of Dasatinib on Viral Persistence and Inflammation in People With HIV Under Antiretroviral Treatment
Dasatinib 70 mg, Placebo - HIV Infection Primary
Phase 2CompletedFundació Institut Germans Trias i Pujol602023-10-162025-09-22
Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201)
PF614, Placebo - Acute Pain
Phase 2CompletedEnsysce Biosciences162023-10-052024-10-08
Low Dose Versus High Dose Methylene Blue in Septic Patients
Normal saline, Methylene Blue low dose, Methylene Blue high dose - Septic Shock
Phase 2 / Phase 3CompletedNational Cancer Institute, Egypt902023-08-012024-07-05
Randomized Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells (PASCs)
PASC transplantation (25 million PASCs/patient), Control - Parkinson Disease
Phase 1 / Phase 2CompletedClusterXStem-Costa Rica402023-06-232026-10-22
Montmorency Cherry Supplementation, Sleep, and Inflammation
Montmorency cherry supplement, Control - Insomnia Chronic, Inflammation
Phase 1 / Phase 2CompletedMichigan State University342023-02-182025-09-08
Add-on Reparixin in Adult Patients With ARDS
Reparixin 600mg, Matching Placebo - Acute Respiratory Distress Syndrome, Adult
Phase 2CompletedDompé Farmaceutici S.p.A662022-12-062026-05-11
Neoadjuvant Chemoradiation Therapy Combined With Immunotherapy for MSS Ultra-low Rectal Cancer
xintilimab injection, Control - Neoadjuvant Chemoradiation Therapy, Rectal Cancer
Phase 2 / Phase 3CompletedChanghai Hospital2012022-10-012026-01-02
the Safety and Efficacy of N-acetyl Cysteine in Children With Drug-Resistant Epilepsy
N-acetyl cysteine, Placebo, NAc - Drug Resistant Epilepsy
Phase 2CompletedTanta University902022-09-152025-07-01
Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.
UC-MSCs, Secretomes, UC-MSCs and Secretomes - Polycystic Ovary Syndrome
Phase 1 / Phase 2CompletedPT. Prodia Stem Cell Indonesia442022-09-012026-02-25
A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy
GSK3228836, GSK3528869A, Control - Hepatitis B, Chronic
Phase 2CompletedGlaxoSmithKline1742022-03-222025-12-30
Dermal Irritation, Sensitization and Cumulative Irritation Potential of 6% Bemotrizinol
6% Bemotrizinol (BEMT) in a basic sunscreen oil formulation, 6% Bemotrizinol (BEMT) dispersion in petrolatum, Sunscreen oil vehicle with 10% ethanol as penetration enhancer without BEMT - Sunburn
Phase 2Completeddsm-firmenich Switzerland AG2242022-02-232022-08-26
Targeting ATR in Soft-tissue Sarcomas
Association of berzosertib with gemcitabine, Gemcitabine - Leiomyosarcoma, Adult
Phase 2CompletedInstitut Bergonié582022-02-092026-05-05
Efficacy and Safety of Metformin Versus Empagliflozin on Chronic Kidney Disease Progression
Metformin, Empagliflozin, Control - Renal Insufficiency, Chronic
Phase 2 / Phase 3CompletedTanta University1182022-01-012025-08-14
Methylene Blue for the Prevention of Hypotension During Hemodialysis
Methylene Blue, Control - Acute Kidney Injury, Shock
Phase 2CompletedFederal University of São Paulo2612021-10-212026-04-17
Effects of Electrical Stimulation and Vitamin D Supplementation on Bone Health Following Spinal Cord Injury.
NMES, Vitamin D, Passive movement - Spinal Cord Injury
Phase 2 / Phase 3CompletedVA Office of Research and Development62021-10-012026-01-23

Showing 20 of 137. Sign in to see all of them.

Conditions studied

COVID-19 (6)  ·  Diabetes Mellitus, Type 2 (5)  ·  Diabetes Mellitus (4)  ·  Inflammation (4)  ·  Motor Activity (4)  ·  Myocardial Infarction (4)  ·  Pain, Postoperative (4)  ·  Spinal Cord Injuries (4)  ·  Alzheimer Disease (3)  ·  Cystic Fibrosis (3)  ·  Heart Failure (3)  ·  Peripheral Arterial Disease (3)  ·  Pneumonia (3)  ·  Pre-Eclampsia (3)  ·  Acute Kidney Injury (2)

Sponsors

Royan Institute (5)  ·  Johns Hopkins University (3)  ·  Assiut University (2)  ·  Dompé Farmaceutici S.p.A (2)  ·  Islamic Azad University, Sanandaj (2)  ·  Mesoblast, Ltd. (2)  ·  National Cancer Institute, Egypt (2)  ·  Tanta University (2)  ·  The Cleveland Clinic (2)  ·  Universidad de Granada (2)  ·  University of Pittsburgh (2)  ·  University of Sao Paulo (2)  ·  VA Office of Research and Development (2)  ·  AbbVie (1)  ·  Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (1)

Countries

United States (52)  ·  Canada (10)  ·  Spain (10)  ·  Egypt (8)  ·  Brazil (7)  ·  Germany (7)  ·  United Kingdom (7)  ·  France (6)  ·  Iran (6)  ·  China (5)  ·  Italy (5)  ·  Mexico (4)  ·  Czechia (3)  ·  Austria (2)  ·  Belgium (2)

Top investigators

Ashraf Moini, MD (2)  ·  Ehab H Shaker, MD (2)  ·  Hamid Gourabi, PhD (2)  ·  Hossein Baharvand, PhD (2)  ·  Julio J Ochoa, Ph.D. (2)  ·  Marzieh Shiva, MD (2)  ·  Paul C Cremer, M. D. (2)  ·  Roger Brown (2)  ·  Santiago A Garcia, MD (2)  ·  A Bhansali (1)  ·  Adriana Andrade, MD, MPH (1)  ·  Aisha K Yousafzai, PhD (1)

Results publications

PMID 33754144, PMID 10439740, PMID 10686270, PMID 11032280, PMID 11425500, PMID 11595691, PMID 11772567, PMID 12088953, PMID 12960545, PMID 15125017, PMID 15781453, PMID 15863172, PMID 16174242, PMID 16473126, PMID 16616662, PMID 16901646, PMID 17297830, PMID 1742815, PMID 17655918, PMID 18385498, PMID 18407790, PMID 18801868, PMID 19128879, PMID 19422355, PMID 19559969, PMID 19618698, PMID 19640281, PMID 19794023, PMID 19944358, PMID 19944914, PMID 20418657, PMID 20495811, PMID 20556751, PMID 21410418, PMID 21452051, PMID 21530398, PMID 21806579, PMID 21907959, PMID 22103808, PMID 22116817, PMID 22221277, PMID 22231013, PMID 22352784, PMID 22505632, PMID 22563751, PMID 22742517, PMID 22776413, PMID 22891807, PMID 22914404, PMID 23034965

NIH funding

2009 (3), 2018 (2), 5KL2TR001109-05 (1), K07CA132916 (1), P01HL103455 (1), R00NR016484 (1), R01CA134903 (1), R01DA012403 (1), R01DA013496 (1), R01DA023877 (1), R01HL042814 (1), R01MH066684 (1), R01NR007652 (1), R01NS052448 (1), R21AT004493 (1)